Compass Therapeutics, Inc. (a Delaware corporation) 35,715,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 3rd, 2021 • Compass Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 3rd, 2021 Company Industry Jurisdiction